Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$685,936
-$234,612 QoQ
Shares Held
120,129
-27.7% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 216 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. ANNX ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in ANNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $685,936 | 120,129 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $920,548 | 166,164 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $321,626 | 64,069 | Shares | Other | 2026-02-17 | |
| 2024-06-30 | $507,115 | 103,493 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,690,728 | 375,276 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $3,213,480 | 707,815 | Shares | Other | 2024-02-14 | |
| 2023-03-31 | $62,654 | 16,274 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $79,840 | 15,443 | Shares | Other | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||